Characterization of the novel antibacterial peptide Leucrocin from crocodile (Crocodylus siamensis) white blood cell extracts

Developmental and Comparative Immunology

Volumn 35, Issue 5, 2011, Pages 545-553

  Pata, Supawadee ^a   Yaraksa, Nualyai ^a   Daduang, Sakda ^a   Temsiripong, Yosapong ^b   Svasti, Jisnuson ^c   Araki, Tomohiro ^d   Thammasirirak, Sompong ^a  

^a Khon Kaen University   (Thailand)

^b Sriracha Moda Farm   (Thailand)

^c Mahidol University   (Thailand)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

Antibacterial activity; Antibacterial peptide; Crocodylus siamensis; Killing mechanism; Leucrocin; White blood cell extracts

Indexed keywords

BETA GALACTOSIDASE; LEUCROCIN I; LEUCROCIN II; LEUCROCIN III; LEUCROCIN IV; LEUKOCYTE EXTRACT; POLYPEPTIDE ANTIBIOTIC AGENT; STREPTOMYCIN; UNCLASSIFIED DRUG;

ALLIGATOR; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; ERYTHROCYTE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHI; STAPHYLOCOCCUS EPIDERMIDIS; VIBRIO CHOLERAE;

BACTERIA (MICROORGANISMS); CROCODYLUS SIAMENSIS; SALMONELLA TYPHI; STAPHYLOCOCCUS EPIDERMIDIS; VIBRIO CHOLERAE;

EID: 79952448588     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2010.12.011     Document Type: Article

References (44)

1. Anderson R.C., Yu P.L. Isolation and characterization of proline/arginine-rich cathelicidin peptides from ovine neutrophils. Biochem. Biophys. Res. Commun. 2003, 312:1139-1146.
2. Becerra F.M., Silva D.A., Ramirez L.D., Hernandez G.M., Vidal Y.L., Soldevila G., et al. Analysis of the antimicrobial activities of a chemokine derived peptide (CDAP-4) on Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 2007, 355(2):352-358.
3. Beck G., Habicht G.S. Immunity and the invertebrates. Sci. Am. 1996, 60-66.
4. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995, 13:61-92.
5. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria. Nat. Rev. Microbiol. 2005, 3(3):238-250.
6. Cabiaux V., Agerberth B., Johansson J., Homble F., Goormaghtigh E., Ruysschaert J.M. Secondary structure and membrane interaction of PR-39, a Pro+Agr-rich antibacterail peptides. Eur. J. Biochem. 1994, 224:1019-1027.
7. Casteels P., Ampe C., Jacobs F., Vaeck M., Tempst P. Apidaecins: antibacterial peptides from honeybees. EMBO J. 1989, 8(8):2387-2391.
8. Dathe M., Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1999, 1462:71-87.
9. Eisenhaver P.B., Harwog S.S.L., Szklarek D., Ganz T., Selsted M.E., Lehrer R.I. Purification and antimicrobial properties of three defensins from rat neutrophils. Infect. Immun. 1989, 57(7):2021-2027.
10. Falla T.J., Karunaratne D.N., Hancocks R.E.W. Mode of action of the antimicrobial peptide Indolicidin. J. Biol. Chem. 1996, 271(32):19298-19303.
11. Ganz T., Lehrer R. Antimicrobial peptides in innate immunity. Development of Novel Antimicrobial Agents, Emerging Strategies 2001, Horizon Scientific Press, Wymondham, UK, p. 138-147.
12. Ganz T., Lehrer R.I. Defensins. Pharmacol. Ther. 1995, 66(2):191-205.
13. Garcia J.R., Krause A., Schulz S., Rodriguez-Jimenez F.J., Kluver E., Adermann K., et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 2001, 15(10):1819-1821.
14. Gudmundsson G.H., Agerberth B. Neutrophil antimicrobial peptides, multifunctional effector molecules in the mammalian immune system. J. Immunol. Methods 1999, 232(1-2):45-54.
15. Hetru C., Bulet P. Strategies for the isolation and characterization of antimicrobial peptides of invertebrates. Antimicrobial Peptide Protocols 1997, 35-49. Humana Press, New Jersey. W.M. Shafer (Ed.).
16. Kalfa V.C., Jia H.P., Kunkle R.A., McCray P.B., Tack B.F., Brogden K.A. Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob. Agents Chemother. 2001, 45(11):3256-3261.
17. Lau S.K., Woo P.C., Woo G.K., Fung A.M., Wong M.K., Chan K.M., et al. Eggerthella hongkongensis sp. nov and Eggerthella sinensis sp. nov., two novel Eggerthella species, account for half of the cases of Eggerthella bacteremia. Diagn. Microbiol. Infect. Dis. 2004, 49(4):255-263.
18. Lehrer R.I., Ladra K.M., Hake R.B. Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig granulocytes. Infect. Immun. 1975, 11:1226-1234.
19. Lehrer R.I., Liehtenstein A.K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 1993, 11:105-128.
20. Levy O., Ooi C.E., Weiss J., Lehrer R.I., Elsbanch P. Individual and synergistic effects of rabbit granulocyte proteins on E. coli. J. Clin. Invest. 1994, 94(2):672-682.
21. Loh B., Grant C., Hancock R.E.W. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1984, 26(4):546-551.
22. Lorin C., Saidi H., Belaid A., Zairi A., Baleux F., Hocini H., et al. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 2005, 334(2):264-275.
23. Mangoni M.L., Papo N., Barra D., Simmaco M., Bozzi A., Giuliodi A., et al. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem. J. 2004, 380:859-865.
24. Merchant M.E., Leger N., Jerkins E., Mills K., Pallansch B.M., Paulman L.R., et al. Broad spectrum antimicrobial activity of white blood cell extracts from the American alligator (Alligator mississippiensis). Vet. Immunol. Immunopathol. 2006, 110:221-228.
25. Merchant M.E., Pallansch M., Paulman R.L., Wells J.B., Nalca A., Ptak R. Antiviral activity of serum from the American alligator (Alligator mississippiensis). Antiviral Res. 2005, 66(1):35-38.
26. Merchant M.E., Roche C., Elsey R.M., Prudhomme J. Antibacterial properties of serum from the American alligator (Alligator mississippiensis). Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 2003, 136(3):505-513.
27. Merchant M.E., Roche C.M., Thibodeaux D., Elsey R.M. Identification of alternative pathway serum complement activity in the blood of the American alligator (Alligator mississippiensis). Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 2005, 141(3):281-288.
28. Nakamura T., Furunaka H., Miyata T., Tokunaga F., Muta T., Iwanaga S., et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J. Biol. Chem. 1988, 263(32):16709-16713.
29. Neu H.C. The crisis in antibiotic resistance. Science 1992, 257:1064-1073.
30. Park C.B., Yi K.S., Matsuzaki K., Kim M.S., Kim S.C. Structure-activity analysis of buforin II, a histone H2A derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8245-8250.
31. Pellegrini A., Waiblinger S., Fellenberg R.V. Purification of equine neutrophil lysozyme and its antibacterial activity against Gram-positive and Gram-negative bacteria. Vet. Res. Commun. 1991, 15(6):427-435.
32. Preecharram S., Daduang S., Bunyatratchata W., Araki T., Thammasirirak S. Antibacterial activity from Siamese crocodile (Crocodylus siamensis) serum. Afr. J. Biotechnol. 2008, 7(17):3121-3128.
33. Preecharram S., Jearranaiprepame P., Daduang S., Temsiripong Y., Somdee T., Fukamizo T., Svasti J., et al. Isolation and characterisation of crocosin, an antibacterial compound from crocodile (Crocodylus siamensis) plasma. Anim. Sci. J. 2010, 81:393-401.
34. Selsted M.E., Brown D.M., DeLange R.J., Harwig S.S.L., Lehrer R.I. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J. Biol. Chem. 1985, 260(8):4579-4584.
35. Selsted M.E., Harwig S.S.L. Purification, primary structure and antimicrobial activities of a guinea pig neutrophil defensin. Infect. Immun. 1987, 55:2181-2186.
36. Selsted M.E., Tang Y.Q., Morris W.L., McGuire P.A., Novotny M.J., Smith W., et al. Purification, primary structures and antimicrobial activities of β-defensins, a new family of antimicrobial peptides from bovine neutrophils. J. Biol. Chem. 1993, 268(9):6641-6648.
37. Shamova O., Brogden K., Zhoa C., Nguyen T., Kokryakov V., Lehrer R.I. Purification and properties of proline-rich antimicrobial peptides from sheep and goat white blood cells. Infect. Immun. 1999, 67(8):4106-4111.
38. Tossi A., Sandri L., Giangaspero A. Amphiphatic α-helical antimicrobial peptides. Biopolymers 2000, 55(1):4-30.
39. Treffers C., Chen L., Anderson C.R., Yu L.P. Isolation and characterization of antimicrobial peptides from deer neutrophils. Int. J. Antimicrob. Agents 2005, 26(2):165-169.
40. Tydell C.C., Yuan J., Tran P., Selsted M.E. Bovine peptidoglycan recognition protein-S: antimicrobial activity, localization, secretion and binding properties. J. Immunol. 2006, 176:1154-1162.
41. Westerhoff H.V., Zasloff M., Rosner J.L., Hendler R.W., Wal D.A., Gomes, et al. Functional synergism of Magainins, PGLa and Magainin-2 in E. coli, tumor cell and liposome. Eur. J. Biochem. 1995, 228(2):257-264.
42. Yeaman M.R., Yount N.Y. Mechanism of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55(1):27-55.
43. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004, 75(1):39-48.
44. Zhu W.L., Song Y.M., Park Y., Park K.H., Yang S.T., Kim J.I., et al. Substitution of the leucine zipper sequence in melittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim. Biophys. Acta 2007, 1768(6):1506-1517.